IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BATTICCIOTTO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.196
EU - Europa 565
AS - Asia 315
SA - Sud America 65
OC - Oceania 31
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.204
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.126
IT - Italia 214
CN - Cina 111
GB - Regno Unito 106
DE - Germania 53
CA - Canada 52
TR - Turchia 42
FR - Francia 33
ES - Italia 32
JP - Giappone 32
BR - Brasile 31
IN - India 26
AU - Australia 25
RU - Federazione Russa 19
HU - Ungheria 16
MX - Messico 16
ZA - Sudafrica 15
KR - Corea 14
NL - Olanda 13
CL - Cile 12
HK - Hong Kong 12
EG - Egitto 11
IE - Irlanda 11
IR - Iran 11
PE - Perù 10
IL - Israele 9
RO - Romania 9
SA - Arabia Saudita 9
VN - Vietnam 8
CH - Svizzera 7
FI - Finlandia 7
TH - Thailandia 7
TW - Taiwan 7
BE - Belgio 6
ID - Indonesia 6
NZ - Nuova Zelanda 6
CO - Colombia 5
MO - Macao, regione amministrativa speciale della Cina 5
UA - Ucraina 5
AT - Austria 4
CZ - Repubblica Ceca 4
MT - Malta 4
PK - Pakistan 4
SE - Svezia 4
SG - Singapore 4
HR - Croazia 3
MY - Malesia 3
NO - Norvegia 3
PT - Portogallo 3
PY - Paraguay 3
AP - ???statistics.table.value.countryCode.AP??? 2
AR - Argentina 2
DK - Danimarca 2
LT - Lituania 2
OM - Oman 2
PL - Polonia 2
UY - Uruguay 2
BH - Bahrain 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
KE - Kenya 1
NG - Nigeria 1
NP - Nepal 1
RS - Serbia 1
SI - Slovenia 1
SO - Somalia 1
Totale 2.204
Salva come PNG Salva come JPEG
Città #
Fairfield 124
Milan 120
Ashburn 101
Houston 82
Woodbridge 78
Seattle 66
Cambridge 53
Buffalo 51
Santa Cruz 40
Ann Arbor 38
Wilmington 33
Los Angeles 18
Southend 17
Beijing 16
Istanbul 14
London 14
Shanghai 14
Tokyo 13
Las Vegas 11
Guangzhou 10
Rochester 10
Budapest 9
Ottawa 9
Santiago 9
Cairo 8
Dublin 8
Fleming Island 8
Hangzhou 8
Muizenberg 8
Phoenix 8
San Francisco 8
Verona 8
Chicago 7
Madrid 7
Ankara 6
Boardman 6
Chennai 6
Mountain View 6
Mumbai 6
Munich 6
New York 6
Orillia 6
Rome 6
Taipei 6
Brooklyn 5
Clearwater 5
Diosd 5
Kowloon 5
Lima 5
Mexico City 5
Milpitas 5
Riyadh 5
Shenzhen 5
Strongsville 5
Toronto 5
Adelaide 4
Alora 4
Ate 4
Bengaluru 4
Birmingham 4
Florence 4
Helsinki 4
Jakarta 4
Leawood 4
Lincoln 4
Melbourne 4
Minnetonka 4
Qala 4
Riva 4
Tehran 4
Windsor 4
Zhengzhou 4
Bangkok 3
Bogen 3
Brisbane 3
Bursa 3
Cassano Magnago 3
Castricum 3
Central 3
Coventry 3
Dammam 3
Dumlupinar 3
Edinburgh 3
Forsyth 3
Goiânia 3
Ho Chi Minh City 3
Lambeth 3
Mexico 3
Nanjing 3
New Delhi 3
Nottingham 3
Palermo 3
Paris 3
Porto Alegre 3
Pretoria 3
Regensburg 3
Richmond 3
Saint Petersburg 3
San Jose 3
Seongdong-gu 3
Totale 1.295
Salva come PNG Salva come JPEG
Nome #
Paradoxical expansion of Th1 and Th17 lymphocytes in rheumatoid arthritis following infliximab treatment: a possible explanation for a lack of clinical response, file dfa8b993-38e8-748b-e053-3a05fe0a3a96 319
Systemic rheumatic diseases : from biological agents to small molecules, file dfa8b99e-285f-748b-e053-3a05fe0a3a96 303
One year in review 2016 : fibromyalgia, file dfa8b99d-f957-748b-e053-3a05fe0a3a96 263
One year in review 2017 : fibromyalgia, file dfa8b99d-e7b0-748b-e053-3a05fe0a3a96 155
Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate, file dfa8b99e-07f8-748b-e053-3a05fe0a3a96 153
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series, file dfa8b99e-2864-748b-e053-3a05fe0a3a96 132
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis : 52-Week Results from the CZP-SPEED Study, file dfa8b99e-1028-748b-e053-3a05fe0a3a96 131
Combined therapeutic approach : Inflammatory bowel diseases and peripheral or axial arthritis, file dfa8b999-552c-748b-e053-3a05fe0a3a96 119
Possible relationship between certolizumab pegol and arrhythmias : Report of two cases, file dfa8b998-33bf-748b-e053-3a05fe0a3a96 117
Measurement of Serum Klotho in Systemic Sclerosis, file dfa8b99e-14f1-748b-e053-3a05fe0a3a96 114
Infections and Biological Therapy in Patients with Rheumatic Diseases, file dfa8b99e-8098-748b-e053-3a05fe0a3a96 113
The immunogenicity of branded and biosimilar infliximab in rheumatoid arthritis according to Th9-related responses, file dfa8b99e-1397-748b-e053-3a05fe0a3a96 111
Economic Evaluation of Tocilizumab Monotherapy Vs Adalimumab Monotherapy In Patients With Rheumatoid Arthritis In Italy, file dfa8b99e-286c-748b-e053-3a05fe0a3a96 104
Interessamento entesitico in bambini e adolescenti con malattia infiammatoria cronica intestinale: uno studio ecografico, file dfa8b999-70b2-748b-e053-3a05fe0a3a96 53
Erratum: Hidden musculoskeletal involvement in inflammatory bowel disease : a multicenter ultrasound study(BMC Musculoskelet Disord. (2016) 17(84) 10.1186/s12891-016-0932-z), file dfa8b99d-f7b4-748b-e053-3a05fe0a3a96 45
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis, file dfa8b99d-da32-748b-e053-3a05fe0a3a96 11
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis : a 6-month real-life observational study, file dfa8b997-f5d5-748b-e053-3a05fe0a3a96 8
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis : a 6-month real-life observational study, file dfa8b998-d0b5-748b-e053-3a05fe0a3a96 8
Low risk of hepatitis B virus reactivation in HBsAg-negative/anti-HBc-positive carriers receiving rituximab for rheumatoid arthritis : a retrospective multicenter Italian study, file dfa8b995-83ef-748b-e053-3a05fe0a3a96 5
Systemic rheumatic diseases : from biological agents to small molecules, file dfa8b99e-3aae-748b-e053-3a05fe0a3a96 5
Paradoxical expansion of Th1 and Th17 lymphocytes in rheumatoid arthritis following infliximab treatment: a possible explanation for a lack of clinical response, file dfa8b993-3ec6-748b-e053-3a05fe0a3a96 4
Rheumatic manifestations in inflammatory bowel disease, file dfa8b99a-0f32-748b-e053-3a05fe0a3a96 3
Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes, file dfa8b99e-06a3-748b-e053-3a05fe0a3a96 3
Interleukin 6 blockade : tocilizumab in psoriatic arthritis, file dfa8b99f-2319-748b-e053-3a05fe0a3a96 3
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients, file dfa8b9a7-d892-748b-e053-3a05fe0a3a96 3
An update on emerging drugs for fibromyalgia treatment, file dfa8b99d-e723-748b-e053-3a05fe0a3a96 2
Paradoxical Expansion of Th1 and TH17 Cells in Peripheral Cultural Blood Cells of RA Patients following Infliximab Treatment : a Possible Correlation with Loss of Clinical Response and Adverse Events, file dfa8b991-61eb-748b-e053-3a05fe0a3a96 1
Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder, file dfa8b99e-a18e-748b-e053-3a05fe0a3a96 1
One year in review 2020: fibromyalgia, file dfa8b9a4-c771-748b-e053-3a05fe0a3a96 1
The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome, file dfa8b9a7-cadf-748b-e053-3a05fe0a3a96 1
Totale 2.291
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.372
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019139 0 0 0 0 0 0 0 1 10 3 82 43
2019/2020492 28 25 26 66 39 33 51 48 61 42 38 35
2020/2021443 25 42 16 50 26 33 62 48 36 37 45 23
2021/2022436 21 28 13 34 56 20 41 36 26 30 91 40
2022/2023480 14 45 83 63 41 20 45 38 22 24 47 38
2023/2024223 26 49 58 33 48 9 0 0 0 0 0 0
Totale 2.291